3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
6
Squamous Cell Carcinoma of Head and Neck
2
Lymphoma, Follicular
2
Head and Neck Neoplasms
2
Recurrence
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hematologic Neoplasms
1
Interventions
fludarabine phosphate
5
Whole-Body Irradiation
5
Mycophenolic Acid
5
Peripheral Blood Stem Cell Transplantation
4
Cyclosporins
4
Cyclosporine
4
carmustine, poliferprosan 20 drug combination
2
Sirolimus
2
Melphalan
2
Etoposide
2
Cytarabine
2
Cyclophosphamide
2
Carmustine
2
venetoclax
1
letermovir
1
ibrutinib
1
Tacrolimus
1
Stem Cell Transplantation
1
Interleukin-15
1
Hematopoietic Stem Cell Transplantation
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic, T-Cell
×
duvelisib
×
Clear all
No trials found.